Methods for amplifying and detecting multiple polynucleotides on a solid phase support

• US 6,500,620 B2
• Filed: 12/19/2000
• Issued: 12/31/2002
• Est. Priority Date: 12/29/1999
• Status: Expired due to Fees

• Current Assignee: Mergen Ltd.
• Original Assignee: Mergen Ltd.
• Inventors: Hu, Qianjin, Yu, Zailin, Peng, Zaoyuan
• Primary Examiner(s): Horlick, Kenneth R.
• Application Number:
  US09/741,983
• Publication Number:
  US 20010036632A1
• Time in Patent Office: 742 Days
• Field of Search: 435/6, 435/91.1, 435/91.2, 435/810, 536/24.33
• US Class Current: 435/6.11
• CPC Class Codes: C12Q 1/6809 Methods for determination or identification of nucleic acids involving differential detection
• CPC Class Codes: C12Q 1/6837 using probe arrays or probe chips C12Q1/6874 takes precedence
• CPC Class Codes: C12Q 1/6851 Quantitative amplification
• CPC Class Codes: C12Q 2531/113 PCR
• CPC Class Codes: C12Q 2565/501 being an array of oligonucleotides
• CPC Class Codes: C12Q 2565/537 characterised by the capture oligonucleotide acting as a primer
• CPC Class Codes: C12Q 2600/158 Expression markers

Abstract

Methods for solid phase polymerase-mediated amplification using immobilized primers on a microarray are provided for detecting and cloning multiple target polynucleotides. The methods, compositions and kits provided herein are useful for research and clinical applications, particularly for large scale assays of genetic information in biological samples of interest.

Claims

1. A method for detecting multiple target polynucleotides in a sample, the method comprising the steps of:

a) providing an array of oligonucleotide primers wherein each array contains at least two groups of oligonucleotide primers immobilized on discrete areas of a solid phase support, each group of oligonucleotide primers selectable for a particular target polynucleotide and comprising primer sequences complementary to a sequence of the particular target polynucleotide;

b) contacting the array with a reaction mixture comprising a sample, said sample containing or suspected of containing multiple target polynucleotides, said reaction mixture further comprising reagents suitable for polynucleotide hybridization and amplification;

c) performing a first round of polymerase-mediated polynucleotide amplification, whereby the target polynucleotides serve as initial templates for the synthesis of optionally detectable nascent polynucleotides which are extended from the immobilized primers;

d) performing a second round of polymerase-mediated polynucleotide amplification in the presence of solution phase primers, wherein the solution phase primers serve as primers and the immobilized nascent polynucleotide strands from step c) serve as templates for the synthesis of detectable amplification products which are extended from the solution phase primers; and

e) detecting the presence and quantity of the synthesized polynucleotides which are captured on discrete areas of the solid phase support via corresponding immobilized primers.

2. The method of claim 1, wherein the solution phase primers are specific for particular target polynucleotides.

3. The method of claim 1, wherein the solution phase primers are universal primers.

4. The method of claim 3, wherein the universal primers are oligo-dT primers.

5. The method of claim 3, wherein the universal primers comprise SP6 promoters, T3 promoters or T7 promoters.

6. The method of claim 1, wherein the reaction mixture comprises a detectable label that is incorporated into the nascent polynucleotides, thereby making the nascent polynucleotides detectable.

7. The method of claim 6, wherein the detectable label is a fluorescent molecule.

8. The method of claim 6, wherein the detectable label is a biotinylated-dNTP or a digoxigenin-dNTP.

9. The method of claim 1, wherein the reaction mixture comprises a first detectable label that specifically binds to a second label which is incorporated into the nascent polynucleotides, thereby making the nascent polynucleotides detectable.

10. The method of claim 9, wherein the second label is a biotinylated-dNTP and first detectable label is a streptavidin conjugated to a fluorescent molecule or an enzymatically activatable molecule.

11. The method of claim 9, wherein the second label is a digoxigenin-dNTP and first detectable label is an anti-digoxigenin antibody conjugated to a fluorescent molecule or an enzymatically activatable molecule.

12. The method of claim 1, wherein the array comprises from at least about 100 to about 100,000 groups of immobilized oligonucleotide primers.

13. The method of claim 12, wherein the array comprises at least about 1,000 groups of immobilized oligonucleotide primers.

14. The method of claim 13, wherein the array comprises at least about 10,000 groups of immobilized oligonucleotide primers.

15. The method of claim 1, wherein the solid phase support is made of material selected from the group consisting of glass, plastics, synthetic polymers, ceramic and nylons.

16. The method of claim 1, wherein the polymerase is Taq DNA polymerase, TthI DNA polymerase, Tne DNA polymerase, Tma DNA polymerase, Pfu DNA polymerase, Vent DNA polymerase or any other thermostable DNA polymerase.

17. A method for detecting and comparing the expression patterns of multiple target polynucleotides from at least two different biological sources, the method comprising the steps of:

a) providing an array of multiple groups of oligonucleotide primers immobilized on a solid phase support, each group of oligonucleotide primers being selected for a particular target polynucleotide and comprising primers complementary to a sequence of a target polynucleotide, wherein target polynucleotides from each biological source contain a covalently linked sequence tag unique to the biological source;

b) contacting the array with a sample comprising multiple target polynucleotides from at least two different biological sources;

c) performing a first round of polymerase-mediated polynucleotide amplification under conditions suitable for polynucleotide hybridization and amplification, whereby the target polynucleotides from the different biological sources serve as initial templates for synthesis of complementary nascent polynucleotide strands which are extended from the immobilized primers;

d) performing a second round of polymerase-mediated polynucleotide amplification in the presence of solution phase sequence tags that are unique to each biological source, wherein the solution phase sequence tags serve as primers and the immobilized nascent polynucleotide strands from step c) serve as templates for the synthesis of new amplification products which are extended from the solution phase sequence tags; and

e) detecting and comparing the immobilized amplification products of the target polynucleotides from the different biological sources.

18. The method of claim 17, wherein the different biological sources are different cells.

19. The method of claim 17, wherein the different biological sources are different tissues.

20. The method of claim 17, wherein the different biological sources are different individuals.

21. The method of claim 17, wherein the different biological sources are different species.

22. The method of claim 17, wherein the amplification products of the target polynucleotides from different biological sources are detected by different labels.

23. The method of claim 22, wherein the labels are fluorescent molecules.

24. The method of claim 22, wherein the labels are biotin or digoxigenin.

25. The method of claim 17, wherein the sequence tags are universal primers.

26. The method of claim 25, wherein the universal primers comprise SP6 promoters, T3 promoters or T7 promoters.

27. A kit for detecting multiple target polynucleotides in a sample, comprising:

a) a solid phase support comprising a plurality of immobilized and separate populations of oligonucleotide primers each population selected to hybridize to a different target polynucleotide, wherein each primer is suitable for conducting a polymerase chain reaction with a specific target polynucleotide to amplify the polynucleotide;

b) one or more populations of solution phase primers each population selected to hybridize to amplification products of one or more target polynucleotides, wherein the solution phase primers are suitable to serve as primers for the synthesis of detectable amplification products which are extended from the solution phase primers;

c) reagents necessary for conducting a polymerase mediated amplification reaction on the solid support; and

d) detection means for detecting amplified polynucleotides on the support.

28. The kit of claim 27, wherein the detection means comprises a label that is incorporated into the amplified polynucleotide during the amplification reaction.

29. The kit of claim 27, wherein the detection means comprises a first label that specifically binds to a second label which is incorporated into the amplified polynucleotide during the amplification reaction.

30. A system for detecting and comparing the expression patterns of multiple target polynucleotides from at least two different biological sources, comprising:

an array comprising at least two groups of oligonucleotide primers immobilized on discrete areas of a solid phase support, each group of oligonucleotide primers being selected for a particular target polynucleotide and comprising primers complementary to a sequence of the particular target polynucleotide, wherein each group is identifiable by its position on the solid support; and

a supply of target polynucleotides from at least two biological sources wherein target nucleotides from each biological source contain a tag that is unique to the biological source.

31. The system of claim 30, wherein the array comprises from at least about 100 to about 100,000 groups of immobilized oligonucleotide primers.

32. The system of claim 31, wherein the array comprises at least about 1,000 groups of immobilized oligonucleotide primers.

33. The system of claim 32, wherein the array comprises at least about 10,000 groups of immobilized oligonucleotide primers.

34. The system of claim 30, wherein the tag is a covalently linked sequence tag.